As of 2026-09-12, the Fair Value of Harvard Bioscience Inc (HBIO) is -11.54 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.03 USD, the upside of Harvard Bioscience Inc is -243.75%.
With the market price of 8.03 USD and our fair value calculation, Harvard Bioscience Inc (HBIO) is not a good investment. Investing in HBIO stocks now will result in a potential loss of 243.75%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -0.30 | -9.50 | -3.41 | -12.41 | -56.70 | -16.46 |
| YoY growth | 96.15% | -3,066.67% | 64.05% | -263.25% | -357.07% | -705.36% |
| Market Cap (mil) | 36.22 |
| P/E | |
| Forward P/E |
| EPS | -2.31 |
| Avg earnings growth rate | -705.36% |
| TTM earnings | -10.41 |